St. Jude Medical
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict St. Jude Medical's revenues will decrease -0.9% and EPS will expand 2.4%.
The average estimate for revenue is $1.43 billion. On the bottom line, the average EPS estimate is $0.87.
Last quarter, St. Jude Medical tallied revenue of $1.40 billion. GAAP reported sales were 1.4% higher than the prior-year quarter's $1.38 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.86. GAAP EPS of $0.67 for Q1 were 5.6% lower than the prior-year quarter's $0.71 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 74.3%, 30 basis points worse than the prior-year quarter. Operating margin was 26.7%, 220 basis points better than the prior-year quarter. Net margin was 15.2%, 170 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $5.70 billion. The average EPS estimate is $3.46.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on St. Jude Medical is outperform, with an average price target of $46.55.
Can your portfolio provide you with enough income to last through retirement? You'll need more than St. Jude Medical. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add St. Jude Medical to My Watchlist.